Skip to main content

and
  1. Article

    Open Access

    Reduced antibody response to SARS-CoV-2 in COVID-19 patients with newly diagnosed diabetes: a retrospective observational study

    The coronavirus disease 2019 (COVID-19) pandemic has dramatically impacted global health, and patients with type 2 diabetes have been identified as a high-risk group for COVID-19 infection and the development ...

    Naoya Otsubo, Tatsuya Fukuda, Hiroko Beppu, Chisato Maki in BMC Endocrine Disorders (2023)

  2. Article

    A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection

    Hemodialysis patients are vulnerable to severe and lethal COVID-19, and their protective immunity against COVID-19 is not yet fully understood. Therefore, we report a case of COVID-19 reinfection in a hemodial...

    Hiroko Beppu, Toshie Ogawa, Masahiro Ishikane, Tomoko Kawanishi in CEN Case Reports (2022)

  3. No Access

    Article

    Efficacy and limitations of additional steroid pulse therapy in IgA nephropathy patients whose hematuria did not remit on tonsillectomy and protocol steroid pulse therapy

    Hematuria is the essential symptom of IgA nephropathy that has been suggested to be associated with long-term renal prognosis, Tonsillectomy and steroid pulse therapy (TSP), which is widely practiced in Japan,...

    Minami Toda, Aya Kume, Masato Hara, Hitomi Kimura in Clinical and Experimental Nephrology (2022)

  4. Article

    Hemodialysis patients with coronavirus disease 2019: reduced antibody response

    Because patients on maintenance hemodialysis (HD) have an impaired immune response to pathogens, they are at higher risk of severe coronavirus disease 2019 (COVID-19). However, data on antibody production amon...

    Hiroko Beppu, Tatsuya Fukuda, Tomoko Kawanishi in Clinical and Experimental Nephrology (2022)